Year|ICCC Group|Age|Event Type|Age-Adjusted Rate|Age-Adjusted CI Lower|Age-Adjusted CI Upper|Count|Population|ICCC.order
1999|All ICCC Groups Combined |0-14|Incidence|145.3|142.1|148.5|8033|55425078|1
1999|All ICCC Groups Combined |0-19|Incidence|157.8|155.0|160.7|11655|73986272|1
1999|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 45.8| 44.1| 47.7|2538|55425078|2
1999|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 41.0| 39.6| 42.5|3033|73986272|2
1999|I(a) Lymphoid leukemias|0-14|Incidence| 35.9| 34.3| 37.5|1989|55425078|3
1999|I(a) Lymphoid leukemias|0-19|Incidence| 30.3| 29.1| 31.6|2244|73986272|3
1999|I(b) Acute myeloid leukemias|0-14|Incidence|  7.6|  6.9|  8.3|419|55425078|4
1999|I(b) Acute myeloid leukemias|0-19|Incidence|  8.1|  7.4|  8.7|595|73986272|4
1999|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  0.6|  0.4|  0.8|33|55425078|5
1999|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  1.0|  0.8|  1.2|73|73986272|5
1999|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|~|~|~|~|55425078|6
1999|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|~|~|~|~|73986272|6
1999|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.6|  1.3|  2.0|89|55425078|7
1999|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.5|  1.3|  1.8|112|73986272|7
1999|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 15.4| 14.4| 16.5|853|55425078|8
1999|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 23.2| 22.1| 24.3|1713|73986272|8
1999|II(a) Hodgkin lymphomas|0-14|Incidence|  5.5|  4.9|  6.1|302|55425078|9
1999|II(a) Hodgkin lymphomas|0-19|Incidence| 11.8| 11.0| 12.6|868|73986272|9
1999|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.0|  5.4|  6.7|331|55425078|10
1999|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  7.6|  7.0|  8.2|560|73986272|10
1999|II(c) Burkitt lymphoma|0-14|Incidence|  2.5|  2.1|  3.0|140|55425078|11
1999|II(c) Burkitt lymphoma|0-19|Incidence|  2.4|  2.1|  2.8|180|73986272|11
1999|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.0|  0.8|  1.3|55|55425078|12
1999|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.8|  0.6|  1.0|57|73986272|12
1999|II(e) Unspecified lymphomas|0-14|Incidence|  0.5|  0.3|  0.7|25|55425078|13
1999|II(e) Unspecified lymphomas|0-19|Incidence|  0.7|  0.5|  0.9|48|73986272|13
1999|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 31.1| 29.7| 32.6|1727|55425078|14
1999|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 28.2| 27.0| 29.5|2090|73986272|14
1999|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.8|  2.4|  3.3|155|55425078|15
1999|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.5|  2.1|  2.9|184|73986272|15
1999|III(b) Astrocytomas|0-14|Incidence| 13.9| 12.9| 14.9|771|55425078|16
1999|III(b) Astrocytomas|0-19|Incidence| 13.1| 12.3| 14.0|972|73986272|16
1999|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  8.0|  7.2|  8.7|442|55425078|17
1999|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.8|  6.2|  7.4|500|73986272|17
1999|III(d) Other gliomas|0-14|Incidence|  5.3|  4.7|  5.9|292|55425078|18
1999|III(d) Other gliomas|0-19|Incidence|  4.7|  4.3|  5.3|352|73986272|18
1999|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.5|  0.3|  0.7|27|55425078|19
1999|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.5|  0.3|  0.7|36|73986272|19
1999|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  1.0|40|55425078|20
1999|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.6|  0.5|  0.8|46|73986272|20
1999|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.4|  9.6| 11.3|571|55425078|21
1999|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.0|  7.4|  8.7|591|73986272|21
1999|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.2|  9.4| 11.1|563|55425078|22
1999|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  7.8|  7.1|  8.4|571|73986272|22
1999|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|55425078|23
1999|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|  0.3|  0.2|  0.4|20|73986272|23
1999|V Retinoblastoma|0-14|Incidence|  4.3|  3.8|  4.9|235|55425078|24
1999|V Retinoblastoma|0-19|Incidence|  3.2|  2.8|  3.7|236|73986272|24
1999|VI Renal tumors|0-14|Incidence|  8.1|  7.3|  8.8|445|55425078|25
1999|VI Renal tumors|0-19|Incidence|  6.4|  5.8|  7.0|472|73986272|25
1999|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  7.6|  6.9|  8.4|420|55425078|26
1999|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  5.8|  5.3|  6.4|429|73986272|26
1999|VI(b) Renal carcinomas|0-14|Incidence|  0.4|  0.3|  0.6|22|55425078|27
1999|VI(b) Renal carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|39|73986272|27
1999|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|55425078|28
1999|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|73986272|28
1999|VII Hepatic tumors|0-14|Incidence|  2.1|  1.7|  2.5|115|55425078|29
1999|VII Hepatic tumors|0-19|Incidence|  2.0|  1.7|  2.3|147|73986272|29
1999|VII(a) Hepatoblastoma|0-14|Incidence|  1.7|  1.4|  2.1|93|55425078|30
1999|VII(a) Hepatoblastoma|0-19|Incidence|  1.3|  1.0|  1.6|94|73986272|30
1999|VII(b) Hepatic carcinomas|0-14|Incidence|  0.4|  0.2|  0.6|22|55425078|31
1999|VII(b) Hepatic carcinomas|0-19|Incidence|  0.7|  0.5|  0.9|52|73986272|31
1999|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|55425078|32
1999|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|73986272|32
1999|VIII Malignant bone tumors|0-14|Incidence|  7.0|  6.3|  7.8|388|55425078|33
1999|VIII Malignant bone tumors|0-19|Incidence|  8.6|  8.0|  9.3|636|73986272|33
1999|VIII(a) Osteosarcomas|0-14|Incidence|  4.1|  3.6|  4.7|228|55425078|34
1999|VIII(a) Osteosarcomas|0-19|Incidence|  5.0|  4.5|  5.5|370|73986272|34
1999|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|55425078|35
1999|VIII(b) Chondrosarcomas|0-19|Incidence|  0.3|  0.2|  0.5|25|73986272|35
1999|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.3|  1.9|  2.8|128|55425078|36
1999|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  2.7|  2.3|  3.1|196|73986272|36
1999|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.3|  0.2|  0.5|18|55425078|37
1999|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.5|  0.3|  0.7|35|73986272|37
1999|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|55425078|38
1999|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|73986272|38
1999|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence|  9.4|  8.6| 10.2|519|55425078|39
1999|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 10.7| 10.0| 11.5|792|73986272|39
1999|IX(a) Rhabdomyosarcomas|0-14|Incidence|  4.9|  4.3|  5.5|271|55425078|40
1999|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.5|  4.1|  5.1|336|73986272|40
1999|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  0.9|  0.7|  1.2|51|55425078|41
1999|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.1|  0.9|  1.4|81|73986272|41
1999|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|55425078|42
1999|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|73986272|42
1999|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  2.5|  2.1|  3.0|140|55425078|43
1999|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  3.8|  3.3|  4.2|279|73986272|43
1999|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.8|  1.3|56|55425078|44
1999|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.3|  1.0|  1.6|94|73986272|44
1999|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.0|  4.5|  5.7|277|55425078|45
1999|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.1|  9.4| 10.9|745|73986272|45
1999|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.3|  1.1|  1.7|74|55425078|46
1999|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.4|  1.1|  1.7|103|73986272|46
1999|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.4|  1.1|  1.8|78|55425078|47
1999|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.4|  1.2|  1.7|104|73986272|47
1999|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.1|  1.7|  2.5|114|55425078|48
1999|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  6.7|  6.1|  7.3|491|73986272|48
1999|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|55425078|49
1999|X(d) Gonadal carcinomas|0-19|Incidence|  0.4|  0.3|  0.6|30|73986272|49
1999|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|55425078|50
1999|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.2|  0.1|  0.4|17|73986272|50
1999|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  5.9|  5.3|  6.6|324|55425078|51
1999|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 15.3| 14.4| 16.2|1126|73986272|51
1999|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|55425078|52
1999|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.1|  0.4|16|73986272|52
1999|XI(b) Thyroid carcinomas|0-14|Incidence|  1.9|  1.5|  2.3|104|55425078|53
1999|XI(b) Thyroid carcinomas|0-19|Incidence|  5.8|  5.3|  6.4|430|73986272|53
1999|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.4|  0.3|  0.6|22|55425078|54
1999|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.4|  0.8|41|73986272|54
1999|XI(d) Malignant melanomas|0-14|Incidence|  1.7|  1.4|  2.1|94|55425078|55
1999|XI(d) Malignant melanomas|0-19|Incidence|  4.6|  4.1|  5.1|338|73986272|55
1999|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|55425078|56
1999|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|73986272|56
1999|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.6|  1.3|  2.0|89|55425078|57
1999|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.0|  3.5|  4.5|294|73986272|57
1999|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.4|  0.3|  0.6|24|55425078|58
1999|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|50|73986272|58
1999|XII(a) Other specified malignant tumors|0-14|Incidence|~|~|~|~|55425078|59
1999|XII(a) Other specified malignant tumors|0-19|Incidence|~|~|~|~|73986272|59
1999|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|16|55425078|60
1999|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.5|  0.4|  0.7|37|73986272|60
1999|Not classified by ICCC|0-14|Incidence|  0.3|  0.2|  0.5|17|55425078|61
1999|Not classified by ICCC|0-19|Incidence|  0.3|  0.2|  0.5|24|73986272|61
2000|All ICCC Groups Combined |0-14|Incidence|148.3|145.1|151.5|8226|55595141|1
2000|All ICCC Groups Combined |0-19|Incidence|162.0|159.1|164.9|12013|74268270|1
2000|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 45.8| 44.0| 47.6|2536|55595141|2
2000|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 41.1| 39.7| 42.6|3044|74268270|2
2000|I(a) Lymphoid leukemias|0-14|Incidence| 37.0| 35.4| 38.6|2046|55595141|3
2000|I(a) Lymphoid leukemias|0-19|Incidence| 31.7| 30.4| 33.0|2345|74268270|3
2000|I(b) Acute myeloid leukemias|0-14|Incidence|  6.5|  5.8|  7.2|358|55595141|4
2000|I(b) Acute myeloid leukemias|0-19|Incidence|  6.9|  6.4|  7.6|515|74268270|4
2000|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  0.8|  0.5|  1.0|42|55595141|5
2000|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  0.9|  0.7|  1.1|65|74268270|5
2000|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|~|~|~|~|55595141|6
2000|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|~|~|~|~|74268270|6
2000|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.5|  1.2|  1.9|84|55595141|7
2000|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.5|  1.2|  1.8|112|74268270|7
2000|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 16.5| 15.4| 17.6|919|55595141|8
2000|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 24.7| 23.6| 25.9|1839|74268270|8
2000|II(a) Hodgkin lymphomas|0-14|Incidence|  5.8|  5.2|  6.5|326|55595141|9
2000|II(a) Hodgkin lymphomas|0-19|Incidence| 12.3| 11.5| 13.1|911|74268270|9
2000|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  5.8|  5.2|  6.5|325|55595141|10
2000|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.1|  7.4|  8.7|599|74268270|10
2000|II(c) Burkitt lymphoma|0-14|Incidence|  2.9|  2.4|  3.4|160|55595141|11
2000|II(c) Burkitt lymphoma|0-19|Incidence|  2.7|  2.4|  3.1|203|74268270|11
2000|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.3|  1.0|  1.6|72|55595141|12
2000|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  1.0|  0.8|  1.3|75|74268270|12
2000|II(e) Unspecified lymphomas|0-14|Incidence|  0.6|  0.5|  0.9|36|55595141|13
2000|II(e) Unspecified lymphomas|0-19|Incidence|  0.7|  0.5|  0.9|51|74268270|13
2000|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 32.4| 30.9| 33.9|1798|55595141|14
2000|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 29.5| 28.3| 30.8|2192|74268270|14
2000|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.7|  2.2|  3.1|147|55595141|15
2000|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.3|  2.0|  2.7|171|74268270|15
2000|III(b) Astrocytomas|0-14|Incidence| 16.5| 15.5| 17.6|919|55595141|16
2000|III(b) Astrocytomas|0-19|Incidence| 15.2| 14.4| 16.2|1132|74268270|16
2000|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.5|  6.8|  8.3|417|55595141|17
2000|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.5|  5.9|  7.1|480|74268270|17
2000|III(d) Other gliomas|0-14|Incidence|  4.5|  3.9|  5.1|248|55595141|18
2000|III(d) Other gliomas|0-19|Incidence|  4.3|  3.8|  4.8|320|74268270|18
2000|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.5|  0.3|  0.7|28|55595141|19
2000|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.5|  0.4|  0.7|37|74268270|19
2000|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  1.0|39|55595141|20
2000|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|52|74268270|20
2000|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence|  9.9|  9.1| 10.8|548|55595141|21
2000|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  7.5|  6.9|  8.2|556|74268270|21
2000|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence|  9.8|  9.0| 10.7|542|55595141|22
2000|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  7.4|  6.8|  8.1|548|74268270|22
2000|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|55595141|23
2000|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|74268270|23
2000|V Retinoblastoma|0-14|Incidence|  4.3|  3.8|  4.9|238|55595141|24
2000|V Retinoblastoma|0-19|Incidence|  3.2|  2.8|  3.7|239|74268270|24
2000|VI Renal tumors|0-14|Incidence|  8.6|  7.9|  9.4|477|55595141|25
2000|VI Renal tumors|0-19|Incidence|  6.7|  6.2|  7.4|497|74268270|25
2000|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  8.2|  7.5|  9.0|455|55595141|26
2000|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  6.2|  5.7|  6.8|459|74268270|26
2000|VI(b) Renal carcinomas|0-14|Incidence|  0.4|  0.2|  0.6|20|55595141|27
2000|VI(b) Renal carcinomas|0-19|Incidence|  0.5|  0.3|  0.7|36|74268270|27
2000|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|55595141|28
2000|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|74268270|28
2000|VII Hepatic tumors|0-14|Incidence|  2.1|  1.8|  2.6|118|55595141|29
2000|VII Hepatic tumors|0-19|Incidence|  1.8|  1.5|  2.1|133|74268270|29
2000|VII(a) Hepatoblastoma|0-14|Incidence|  1.9|  1.6|  2.3|106|55595141|30
2000|VII(a) Hepatoblastoma|0-19|Incidence|  1.4|  1.2|  1.7|106|74268270|30
2000|VII(b) Hepatic carcinomas|0-14|Incidence|~|~|~|~|55595141|31
2000|VII(b) Hepatic carcinomas|0-19|Incidence|  0.4|  0.2|  0.5|27|74268270|31
2000|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|55595141|32
2000|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|74268270|32
2000|VIII Malignant bone tumors|0-14|Incidence|  6.7|  6.0|  7.4|372|55595141|33
2000|VIII Malignant bone tumors|0-19|Incidence|  8.4|  7.8|  9.1|626|74268270|33
2000|VIII(a) Osteosarcomas|0-14|Incidence|  3.6|  3.1|  4.2|202|55595141|34
2000|VIII(a) Osteosarcomas|0-19|Incidence|  4.7|  4.2|  5.2|351|74268270|34
2000|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|55595141|35
2000|VIII(b) Chondrosarcomas|0-19|Incidence|~|~|~|~|74268270|35
2000|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.7|  2.3|  3.2|151|55595141|36
2000|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  3.1|  2.7|  3.5|228|74268270|36
2000|VIII(d) Other specified malignant bone tumors|0-14|Incidence|~|~|~|~|55595141|37
2000|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.2|  0.1|  0.4|17|74268270|37
2000|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|55595141|38
2000|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|  0.2|  0.1|  0.4|17|74268270|38
2000|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.5|  9.7| 11.4|583|55595141|39
2000|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.9| 11.2| 12.8|887|74268270|39
2000|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.3|  4.7|  5.9|292|55595141|40
2000|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.9|  4.4|  5.4|360|74268270|40
2000|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.0|  0.7|  1.3|54|55595141|41
2000|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.2|  1.0|  1.5|92|74268270|41
2000|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|55595141|42
2000|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|74268270|42
2000|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.2|  2.7|  3.7|176|55595141|43
2000|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.4|  3.9|  4.9|328|74268270|43
2000|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.1|  0.8|  1.4|60|55595141|44
2000|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.4|  1.1|  1.7|103|74268270|44
2000|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.0|  4.4|  5.6|278|55595141|45
2000|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.7| 10.0| 11.5|795|74268270|45
2000|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.4|  1.1|  1.8|80|55595141|46
2000|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.6|  1.4|  2.0|122|74268270|46
2000|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.1|  0.8|  1.4|61|55595141|47
2000|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.4|  1.1|  1.7|102|74268270|47
2000|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.3|  1.9|  2.7|126|55595141|48
2000|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  7.0|  6.4|  7.6|520|74268270|48
2000|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|55595141|49
2000|X(d) Gonadal carcinomas|0-19|Incidence|  0.5|  0.3|  0.7|36|74268270|49
2000|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|55595141|50
2000|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|~|~|~|~|74268270|50
2000|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  5.6|  5.0|  6.2|310|55595141|51
2000|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 15.3| 14.4| 16.2|1137|74268270|51
2000|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|55595141|52
2000|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.3|  0.2|  0.4|22|74268270|52
2000|XI(b) Thyroid carcinomas|0-14|Incidence|  1.8|  1.5|  2.2|100|55595141|53
2000|XI(b) Thyroid carcinomas|0-19|Incidence|  5.6|  5.1|  6.2|416|74268270|53
2000|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|19|55595141|54
2000|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|40|74268270|54
2000|XI(d) Malignant melanomas|0-14|Incidence|  1.6|  1.3|  2.0|91|55595141|55
2000|XI(d) Malignant melanomas|0-19|Incidence|  4.9|  4.4|  5.4|364|74268270|55
2000|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|55595141|56
2000|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|74268270|56
2000|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.5|  1.2|  1.8|82|55595141|57
2000|XI(f) Other and unspecified carcinomas|0-19|Incidence|  3.9|  3.5|  4.4|289|74268270|57
2000|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.6|  0.4|  0.8|33|55595141|58
2000|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.6|  0.5|  0.9|48|74268270|58
2000|XII(a) Other specified malignant tumors|0-14|Incidence|~|~|~|~|55595141|59
2000|XII(a) Other specified malignant tumors|0-19|Incidence|~|~|~|~|74268270|59
2000|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.4|  0.2|  0.6|20|55595141|60
2000|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.4|  0.3|  0.6|33|74268270|60
2000|Not classified by ICCC|0-14|Incidence|  0.3|  0.2|  0.5|16|55595141|61
2000|Not classified by ICCC|0-19|Incidence|  0.3|  0.2|  0.4|20|74268270|61
2001|All ICCC Groups Combined |0-14|Incidence|155.5|152.3|158.8|8698|55948589|1
2001|All ICCC Groups Combined |0-19|Incidence|169.6|166.6|172.6|12668|74722264|1
2001|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 50.5| 48.7| 52.4|2813|55948589|2
2001|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 45.5| 44.0| 47.0|3386|74722264|2
2001|I(a) Lymphoid leukemias|0-14|Incidence| 38.8| 37.2| 40.5|2155|55948589|3
2001|I(a) Lymphoid leukemias|0-19|Incidence| 33.1| 31.8| 34.4|2457|74722264|3
2001|I(b) Acute myeloid leukemias|0-14|Incidence|  7.3|  6.7|  8.1|412|55948589|4
2001|I(b) Acute myeloid leukemias|0-19|Incidence|  7.7|  7.1|  8.4|577|74722264|4
2001|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.6|  1.3|  2.0|92|55948589|5
2001|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  2.1|  1.7|  2.4|154|74722264|5
2001|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|  1.6|  1.3|  2.0|91|55948589|6
2001|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|  1.5|  1.2|  1.8|110|74722264|6
2001|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.1|  0.9|  1.4|63|55948589|7
2001|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.2|  0.9|  1.5|88|74722264|7
2001|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 16.1| 15.1| 17.2|906|55948589|8
2001|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 24.8| 23.7| 26.0|1859|74722264|8
2001|II(a) Hodgkin lymphomas|0-14|Incidence|  5.9|  5.3|  6.6|332|55948589|9
2001|II(a) Hodgkin lymphomas|0-19|Incidence| 12.7| 11.9| 13.5|947|74722264|9
2001|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.7|  6.0|  7.4|375|55948589|10
2001|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.9|  8.2|  9.6|662|74722264|10
2001|II(c) Burkitt lymphoma|0-14|Incidence|  2.3|  1.9|  2.7|128|55948589|11
2001|II(c) Burkitt lymphoma|0-19|Incidence|  2.2|  1.9|  2.6|164|74722264|11
2001|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  0.9|  0.7|  1.2|53|55948589|12
2001|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|54|74722264|12
2001|II(e) Unspecified lymphomas|0-14|Incidence|  0.3|  0.2|  0.5|18|55948589|13
2001|II(e) Unspecified lymphomas|0-19|Incidence|  0.4|  0.3|  0.6|32|74722264|13
2001|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 32.2| 30.7| 33.7|1796|55948589|14
2001|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 29.5| 28.3| 30.7|2200|74722264|14
2001|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.7|  2.3|  3.2|151|55948589|15
2001|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.4|  2.0|  2.7|176|74722264|15
2001|III(b) Astrocytomas|0-14|Incidence| 15.9| 14.8| 17.0|886|55948589|16
2001|III(b) Astrocytomas|0-19|Incidence| 14.7| 13.8| 15.5|1093|74722264|16
2001|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.2|  6.6|  8.0|404|55948589|17
2001|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.6|  6.0|  7.2|489|74722264|17
2001|III(d) Other gliomas|0-14|Incidence|  5.3|  4.7|  5.9|296|55948589|18
2001|III(d) Other gliomas|0-19|Incidence|  4.9|  4.4|  5.5|369|74722264|18
2001|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  0.9|37|55948589|19
2001|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.6|  0.4|  0.8|44|74722264|19
2001|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.4|  0.2|  0.6|22|55948589|20
2001|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.4|  0.3|  0.6|29|74722264|20
2001|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 11.6| 10.7| 12.5|651|55948589|21
2001|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.8|  8.2|  9.5|663|74722264|21
2001|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 11.5| 10.6| 12.4|646|55948589|22
2001|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  8.7|  8.1|  9.4|653|74722264|22
2001|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|55948589|23
2001|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|74722264|23
2001|V Retinoblastoma|0-14|Incidence|  4.4|  3.8|  4.9|245|55948589|24
2001|V Retinoblastoma|0-19|Incidence|  3.3|  2.9|  3.7|245|74722264|24
2001|VI Renal tumors|0-14|Incidence|  8.5|  7.8|  9.3|475|55948589|25
2001|VI Renal tumors|0-19|Incidence|  6.7|  6.2|  7.3|500|74722264|25
2001|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  8.2|  7.4|  8.9|453|55948589|26
2001|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  6.1|  5.6|  6.7|456|74722264|26
2001|VI(b) Renal carcinomas|0-14|Incidence|  0.4|  0.2|  0.5|20|55948589|27
2001|VI(b) Renal carcinomas|0-19|Incidence|  0.6|  0.4|  0.8|42|74722264|27
2001|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|55948589|28
2001|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|74722264|28
2001|VII Hepatic tumors|0-14|Incidence|  2.1|  1.7|  2.5|117|55948589|29
2001|VII Hepatic tumors|0-19|Incidence|  1.8|  1.5|  2.1|136|74722264|29
2001|VII(a) Hepatoblastoma|0-14|Incidence|  1.7|  1.4|  2.0|94|55948589|30
2001|VII(a) Hepatoblastoma|0-19|Incidence|  1.3|  1.0|  1.5|95|74722264|30
2001|VII(b) Hepatic carcinomas|0-14|Incidence|  0.4|  0.2|  0.6|22|55948589|31
2001|VII(b) Hepatic carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|40|74722264|31
2001|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|55948589|32
2001|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|74722264|32
2001|VIII Malignant bone tumors|0-14|Incidence|  6.9|  6.2|  7.6|388|55948589|33
2001|VIII Malignant bone tumors|0-19|Incidence|  9.3|  8.7| 10.1|700|74722264|33
2001|VIII(a) Osteosarcomas|0-14|Incidence|  3.7|  3.3|  4.3|211|55948589|34
2001|VIII(a) Osteosarcomas|0-19|Incidence|  5.1|  4.6|  5.6|383|74722264|34
2001|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|55948589|35
2001|VIII(b) Chondrosarcomas|0-19|Incidence|  0.3|  0.2|  0.5|26|74722264|35
2001|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.7|  2.3|  3.2|153|55948589|36
2001|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  3.4|  3.0|  3.8|252|74722264|36
2001|VIII(d) Other specified malignant bone tumors|0-14|Incidence|~|~|~|~|55948589|37
2001|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.4|  0.3|  0.6|30|74722264|37
2001|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|55948589|38
2001|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|74722264|38
2001|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.5|  9.7| 11.4|588|55948589|39
2001|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.8| 11.0| 12.6|883|74722264|39
2001|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.2|  4.6|  5.8|289|55948589|40
2001|IX(a) Rhabdomyosarcomas|0-19|Incidence|  5.0|  4.5|  5.5|373|74722264|40
2001|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.3|  1.0|  1.6|72|55948589|41
2001|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.4|  1.2|  1.7|109|74722264|41
2001|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|55948589|42
2001|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|74722264|42
2001|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.0|  2.6|  3.5|171|55948589|43
2001|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.1|  3.6|  4.5|305|74722264|43
2001|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.7|  1.3|56|55948589|44
2001|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.2|  1.0|  1.5|93|74722264|44
2001|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.1|  4.5|  5.7|287|55948589|45
2001|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.5|  9.8| 11.3|788|74722264|45
2001|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.3|  1.0|  1.6|73|55948589|46
2001|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.6|  1.3|  1.9|120|74722264|46
2001|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.4|  1.1|  1.8|80|55948589|47
2001|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.6|  1.4|  1.9|123|74722264|47
2001|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.1|  1.7|  2.5|116|55948589|48
2001|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  6.7|  6.1|  7.3|498|74722264|48
2001|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|55948589|49
2001|X(d) Gonadal carcinomas|0-19|Incidence|  0.4|  0.2|  0.5|27|74722264|49
2001|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|55948589|50
2001|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.3|  0.2|  0.4|20|74722264|50
2001|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  6.7|  6.0|  7.4|378|55948589|51
2001|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 16.4| 15.5| 17.4|1229|74722264|51
2001|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|55948589|52
2001|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.1|  0.3|16|74722264|52
2001|XI(b) Thyroid carcinomas|0-14|Incidence|  2.4|  2.0|  2.8|136|55948589|53
2001|XI(b) Thyroid carcinomas|0-19|Incidence|  5.8|  5.3|  6.4|434|74722264|53
2001|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|19|55948589|54
2001|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.4|  0.8|43|74722264|54
2001|XI(d) Malignant melanomas|0-14|Incidence|  1.9|  1.6|  2.3|109|55948589|55
2001|XI(d) Malignant melanomas|0-19|Incidence|  5.7|  5.2|  6.3|430|74722264|55
2001|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|55948589|56
2001|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|74722264|56
2001|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.7|  1.4|  2.1|96|55948589|57
2001|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.0|  3.6|  4.5|302|74722264|57
2001|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.6|  0.4|  0.8|32|55948589|58
2001|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|51|74722264|58
2001|XII(a) Other specified malignant tumors|0-14|Incidence|  0.4|  0.2|  0.6|21|55948589|59
2001|XII(a) Other specified malignant tumors|0-19|Incidence|  0.4|  0.2|  0.5|28|74722264|59
2001|XII(b) Other unspecified malignant tumors|0-14|Incidence|~|~|~|~|55948589|60
2001|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.3|  0.2|  0.5|23|74722264|60
2001|Not classified by ICCC|0-14|Incidence|  0.4|  0.2|  0.6|22|55948589|61
2001|Not classified by ICCC|0-19|Incidence|  0.4|  0.2|  0.5|28|74722264|61
2002|All ICCC Groups Combined |0-14|Incidence|152.7|149.5|156.0|8590|56203020|1
2002|All ICCC Groups Combined |0-19|Incidence|167.9|165.0|170.9|12614|75077963|1
2002|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 48.8| 47.0| 50.7|2736|56203020|2
2002|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 44.3| 42.8| 45.9|3321|75077963|2
2002|I(a) Lymphoid leukemias|0-14|Incidence| 36.5| 34.9| 38.1|2040|56203020|3
2002|I(a) Lymphoid leukemias|0-19|Incidence| 31.5| 30.2| 32.8|2353|75077963|3
2002|I(b) Acute myeloid leukemias|0-14|Incidence|  7.9|  7.2|  8.7|448|56203020|4
2002|I(b) Acute myeloid leukemias|0-19|Incidence|  8.2|  7.6|  8.9|620|75077963|4
2002|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.5|  1.2|  1.8|83|56203020|5
2002|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  1.9|  1.6|  2.2|143|75077963|5
2002|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|  1.6|  1.3|  2.0|90|56203020|6
2002|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|  1.5|  1.2|  1.8|113|75077963|6
2002|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.3|  1.1|  1.7|75|56203020|7
2002|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.2|  1.0|  1.5|92|75077963|7
2002|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 15.6| 14.6| 16.7|882|56203020|8
2002|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 24.3| 23.2| 25.4|1828|75077963|8
2002|II(a) Hodgkin lymphomas|0-14|Incidence|  5.3|  4.7|  5.9|302|56203020|9
2002|II(a) Hodgkin lymphomas|0-19|Incidence| 12.1| 11.3| 12.9|912|75077963|9
2002|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.2|  5.6|  6.9|349|56203020|10
2002|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.3|  7.6|  9.0|622|75077963|10
2002|II(c) Burkitt lymphoma|0-14|Incidence|  2.8|  2.4|  3.3|157|56203020|11
2002|II(c) Burkitt lymphoma|0-19|Incidence|  2.8|  2.4|  3.2|208|75077963|11
2002|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.1|  0.8|  1.4|61|56203020|12
2002|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.8|  0.6|  1.1|62|75077963|12
2002|II(e) Unspecified lymphomas|0-14|Incidence|~|~|~|~|56203020|13
2002|II(e) Unspecified lymphomas|0-19|Incidence|  0.3|  0.2|  0.5|24|75077963|13
2002|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 33.2| 31.7| 34.8|1863|56203020|14
2002|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 30.2| 28.9| 31.4|2260|75077963|14
2002|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  3.6|  3.2|  4.2|205|56203020|15
2002|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  3.0|  2.6|  3.4|225|75077963|15
2002|III(b) Astrocytomas|0-14|Incidence| 15.4| 14.4| 16.5|864|56203020|16
2002|III(b) Astrocytomas|0-19|Incidence| 14.4| 13.6| 15.3|1083|75077963|16
2002|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.4|  6.7|  8.2|415|56203020|17
2002|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.4|  5.8|  7.0|477|75077963|17
2002|III(d) Other gliomas|0-14|Incidence|  5.7|  5.0|  6.3|316|56203020|18
2002|III(d) Other gliomas|0-19|Incidence|  5.2|  4.7|  5.8|392|75077963|18
2002|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  1.0|42|56203020|19
2002|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.7|  0.6|  1.0|56|75077963|19
2002|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.4|  0.2|  0.6|21|56203020|20
2002|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.4|  0.2|  0.5|27|75077963|20
2002|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.7|  9.9| 11.6|605|56203020|21
2002|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.2|  7.6|  8.9|619|75077963|21
2002|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.7|  9.8| 11.5|601|56203020|22
2002|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  8.0|  7.4|  8.7|605|75077963|22
2002|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|56203020|23
2002|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|75077963|23
2002|V Retinoblastoma|0-14|Incidence|  3.7|  3.2|  4.3|211|56203020|24
2002|V Retinoblastoma|0-19|Incidence|  2.8|  2.4|  3.2|211|75077963|24
2002|VI Renal tumors|0-14|Incidence|  8.1|  7.4|  8.9|456|56203020|25
2002|VI Renal tumors|0-19|Incidence|  6.4|  5.8|  7.0|476|75077963|25
2002|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  7.9|  7.2|  8.7|445|56203020|26
2002|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  6.0|  5.4|  6.6|448|75077963|26
2002|VI(b) Renal carcinomas|0-14|Incidence|~|~|~|~|56203020|27
2002|VI(b) Renal carcinomas|0-19|Incidence|  0.4|  0.2|  0.5|27|75077963|27
2002|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|56203020|28
2002|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|75077963|28
2002|VII Hepatic tumors|0-14|Incidence|  1.9|  1.6|  2.3|109|56203020|29
2002|VII Hepatic tumors|0-19|Incidence|  1.7|  1.4|  2.0|127|75077963|29
2002|VII(a) Hepatoblastoma|0-14|Incidence|  1.6|  1.3|  1.9|89|56203020|30
2002|VII(a) Hepatoblastoma|0-19|Incidence|  1.2|  1.0|  1.5|90|75077963|30
2002|VII(b) Hepatic carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|19|56203020|31
2002|VII(b) Hepatic carcinomas|0-19|Incidence|  0.5|  0.3|  0.7|36|75077963|31
2002|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|56203020|32
2002|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|75077963|32
2002|VIII Malignant bone tumors|0-14|Incidence|  6.8|  6.1|  7.5|385|56203020|33
2002|VIII Malignant bone tumors|0-19|Incidence|  9.0|  8.3|  9.7|679|75077963|33
2002|VIII(a) Osteosarcomas|0-14|Incidence|  3.7|  3.2|  4.2|210|56203020|34
2002|VIII(a) Osteosarcomas|0-19|Incidence|  4.9|  4.4|  5.4|367|75077963|34
2002|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|56203020|35
2002|VIII(b) Chondrosarcomas|0-19|Incidence|  0.5|  0.3|  0.6|35|75077963|35
2002|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.5|  2.1|  3.0|143|56203020|36
2002|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  3.0|  2.6|  3.5|228|75077963|36
2002|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.3|  0.2|  0.5|19|56203020|37
2002|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.5|  0.3|  0.7|37|75077963|37
2002|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|56203020|38
2002|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|75077963|38
2002|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.9| 10.1| 11.8|616|56203020|39
2002|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.8| 11.0| 12.6|886|75077963|39
2002|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.5|  4.9|  6.1|308|56203020|40
2002|IX(a) Rhabdomyosarcomas|0-19|Incidence|  5.0|  4.5|  5.5|373|75077963|40
2002|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.2|  0.9|  1.5|68|56203020|41
2002|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.2|  1.0|  1.5|90|75077963|41
2002|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|56203020|42
2002|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|75077963|42
2002|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.3|  2.8|  3.8|187|56203020|43
2002|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.6|  4.1|  5.1|348|75077963|43
2002|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  0.9|  0.7|  1.2|53|56203020|44
2002|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.0|  0.8|  1.2|75|75077963|44
2002|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.4|  4.8|  6.0|305|56203020|45
2002|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 11.0| 10.3| 11.8|832|75077963|45
2002|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.4|  1.1|  1.8|82|56203020|46
2002|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.6|  1.4|  2.0|124|75077963|46
2002|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.5|  1.2|  1.8|84|56203020|47
2002|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.6|  1.3|  1.9|119|75077963|47
2002|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.3|  1.9|  2.7|130|56203020|48
2002|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  7.2|  6.7|  7.9|545|75077963|48
2002|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|56203020|49
2002|X(d) Gonadal carcinomas|0-19|Incidence|  0.3|  0.2|  0.5|23|75077963|49
2002|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|56203020|50
2002|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.3|  0.2|  0.4|21|75077963|50
2002|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  6.5|  5.8|  7.2|368|56203020|51
2002|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 17.2| 16.2| 18.1|1291|75077963|51
2002|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|56203020|52
2002|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.3|  0.2|  0.4|19|75077963|52
2002|XI(b) Thyroid carcinomas|0-14|Incidence|  1.8|  1.5|  2.2|103|56203020|53
2002|XI(b) Thyroid carcinomas|0-19|Incidence|  5.6|  5.1|  6.1|420|75077963|53
2002|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|~|~|~|~|56203020|54
2002|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.5|  0.8|48|75077963|54
2002|XI(d) Malignant melanomas|0-14|Incidence|  2.3|  1.9|  2.7|131|56203020|55
2002|XI(d) Malignant melanomas|0-19|Incidence|  6.5|  6.0|  7.1|492|75077963|55
2002|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|56203020|56
2002|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|75077963|56
2002|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.8|  1.4|  2.1|100|56203020|57
2002|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.0|  3.6|  4.5|304|75077963|57
2002|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.5|  0.4|  0.8|31|56203020|58
2002|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.8|  0.6|  1.0|57|75077963|58
2002|XII(a) Other specified malignant tumors|0-14|Incidence|  0.4|  0.2|  0.5|20|56203020|59
2002|XII(a) Other specified malignant tumors|0-19|Incidence|  0.5|  0.3|  0.6|35|75077963|59
2002|XII(b) Other unspecified malignant tumors|0-14|Incidence|~|~|~|~|56203020|60
2002|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.3|  0.2|  0.4|22|75077963|60
2002|Not classified by ICCC|0-14|Incidence|  0.4|  0.3|  0.6|23|56203020|61
2002|Not classified by ICCC|0-19|Incidence|  0.4|  0.2|  0.5|27|75077963|61
2003|All ICCC Groups Combined |0-14|Incidence|148.3|145.2|151.5|8698|58432094|1
2003|All ICCC Groups Combined |0-19|Incidence|164.1|161.3|167.0|12858|78139655|1
2003|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 46.8| 45.0| 48.6|2733|58432094|2
2003|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 42.6| 41.1| 44.0|3325|78139655|2
2003|I(a) Lymphoid leukemias|0-14|Incidence| 35.6| 34.1| 37.1|2073|58432094|3
2003|I(a) Lymphoid leukemias|0-19|Incidence| 30.4| 29.2| 31.6|2367|78139655|3
2003|I(b) Acute myeloid leukemias|0-14|Incidence|  7.4|  6.7|  8.1|433|58432094|4
2003|I(b) Acute myeloid leukemias|0-19|Incidence|  7.7|  7.1|  8.3|603|78139655|4
2003|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.3|  1.0|  1.7|78|58432094|5
2003|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  2.1|  1.8|  2.4|162|78139655|5
2003|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|  1.6|  1.3|  2.0|96|58432094|6
2003|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|  1.5|  1.2|  1.8|118|78139655|6
2003|I(e) Unspecified and other specified leukemias|0-14|Incidence|  0.9|  0.7|  1.2|53|58432094|7
2003|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.0|  0.7|  1.2|75|78139655|7
2003|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 15.6| 14.6| 16.7|916|58432094|8
2003|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 23.8| 22.8| 25.0|1868|78139655|8
2003|II(a) Hodgkin lymphomas|0-14|Incidence|  5.8|  5.2|  6.4|341|58432094|9
2003|II(a) Hodgkin lymphomas|0-19|Incidence| 12.4| 11.6| 13.2|973|78139655|9
2003|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.2|  5.5|  6.8|360|58432094|10
2003|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  7.9|  7.3|  8.6|620|78139655|10
2003|II(c) Burkitt lymphoma|0-14|Incidence|  2.6|  2.2|  3.1|152|58432094|11
2003|II(c) Burkitt lymphoma|0-19|Incidence|  2.6|  2.2|  2.9|199|78139655|11
2003|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.0|  0.7|  1.3|57|58432094|12
2003|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.8|  0.6|  1.0|60|78139655|12
2003|II(e) Unspecified lymphomas|0-14|Incidence|~|~|~|~|58432094|13
2003|II(e) Unspecified lymphomas|0-19|Incidence|  0.2|  0.1|  0.3|16|78139655|13
2003|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 31.3| 29.9| 32.8|1827|58432094|14
2003|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 28.7| 27.5| 29.9|2239|78139655|14
2003|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.5|  2.1|  2.9|145|58432094|15
2003|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.3|  2.0|  2.7|180|78139655|15
2003|III(b) Astrocytomas|0-14|Incidence| 15.1| 14.1| 16.1|879|58432094|16
2003|III(b) Astrocytomas|0-19|Incidence| 14.2| 13.4| 15.1|1111|78139655|16
2003|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.3|  6.6|  8.0|423|58432094|17
2003|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.2|  5.6|  6.8|481|78139655|17
2003|III(d) Other gliomas|0-14|Incidence|  5.5|  4.9|  6.1|319|58432094|18
2003|III(d) Other gliomas|0-19|Incidence|  5.0|  4.5|  5.5|389|78139655|18
2003|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.7|  0.5|  1.0|43|58432094|19
2003|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|51|78139655|19
2003|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.3|  0.2|  0.5|18|58432094|20
2003|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.3|  0.2|  0.5|27|78139655|20
2003|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.5|  9.7| 11.3|619|58432094|21
2003|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.0|  7.4|  8.7|633|78139655|21
2003|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.3|  9.5| 11.2|611|58432094|22
2003|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  7.9|  7.3|  8.5|621|78139655|22
2003|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|58432094|23
2003|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|~|~|~|~|78139655|23
2003|V Retinoblastoma|0-14|Incidence|  3.8|  3.3|  4.3|223|58432094|24
2003|V Retinoblastoma|0-19|Incidence|  2.8|  2.5|  3.2|225|78139655|24
2003|VI Renal tumors|0-14|Incidence|  8.4|  7.7|  9.2|491|58432094|25
2003|VI Renal tumors|0-19|Incidence|  6.6|  6.0|  7.2|513|78139655|25
2003|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  8.0|  7.3|  8.8|470|58432094|26
2003|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  6.0|  5.5|  6.6|473|78139655|26
2003|VI(b) Renal carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|17|58432094|27
2003|VI(b) Renal carcinomas|0-19|Incidence|  0.5|  0.3|  0.6|36|78139655|27
2003|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|58432094|28
2003|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|78139655|28
2003|VII Hepatic tumors|0-14|Incidence|  2.5|  2.1|  2.9|147|58432094|29
2003|VII Hepatic tumors|0-19|Incidence|  2.2|  1.9|  2.5|172|78139655|29
2003|VII(a) Hepatoblastoma|0-14|Incidence|  2.0|  1.7|  2.4|119|58432094|30
2003|VII(a) Hepatoblastoma|0-19|Incidence|  1.5|  1.2|  1.8|119|78139655|30
2003|VII(b) Hepatic carcinomas|0-14|Incidence|  0.5|  0.3|  0.7|28|58432094|31
2003|VII(b) Hepatic carcinomas|0-19|Incidence|  0.7|  0.5|  0.9|52|78139655|31
2003|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|58432094|32
2003|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|78139655|32
2003|VIII Malignant bone tumors|0-14|Incidence|  6.6|  6.0|  7.3|392|58432094|33
2003|VIII Malignant bone tumors|0-19|Incidence|  8.6|  8.0|  9.3|679|78139655|33
2003|VIII(a) Osteosarcomas|0-14|Incidence|  3.8|  3.3|  4.3|222|58432094|34
2003|VIII(a) Osteosarcomas|0-19|Incidence|  5.3|  4.8|  5.8|418|78139655|34
2003|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|58432094|35
2003|VIII(b) Chondrosarcomas|0-19|Incidence|  0.3|  0.2|  0.4|20|78139655|35
2003|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.2|  1.9|  2.7|132|58432094|36
2003|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  2.6|  2.3|  3.0|204|78139655|36
2003|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.3|  0.2|  0.4|16|58432094|37
2003|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.3|  0.2|  0.5|26|78139655|37
2003|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|58432094|38
2003|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|78139655|38
2003|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.5|  9.7| 11.4|618|58432094|39
2003|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 12.0| 11.3| 12.8|942|78139655|39
2003|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.2|  4.6|  5.8|303|58432094|40
2003|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.9|  4.4|  5.4|380|78139655|40
2003|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.0|  0.7|  1.3|57|58432094|41
2003|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.4|  1.1|  1.7|109|78139655|41
2003|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|58432094|42
2003|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|78139655|42
2003|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.4|  2.9|  3.9|199|58432094|43
2003|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.5|  4.1|  5.0|356|78139655|43
2003|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.7|  1.2|57|58432094|44
2003|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.2|  1.0|  1.5|94|78139655|44
2003|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.0|  4.5|  5.6|299|58432094|45
2003|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.3|  9.6| 11.0|811|78139655|45
2003|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.1|  0.9|  1.4|66|58432094|46
2003|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.3|  1.1|  1.6|106|78139655|46
2003|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.4|  1.2|  1.8|86|58432094|47
2003|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.5|  1.2|  1.8|116|78139655|47
2003|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.2|  1.9|  2.6|132|58432094|48
2003|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  6.8|  6.2|  7.4|531|78139655|48
2003|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|58432094|49
2003|X(d) Gonadal carcinomas|0-19|Incidence|  0.4|  0.2|  0.5|28|78139655|49
2003|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|58432094|50
2003|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.4|  0.3|  0.5|30|78139655|50
2003|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  6.3|  5.7|  7.0|376|58432094|51
2003|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 17.3| 16.3| 18.2|1356|78139655|51
2003|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|58432094|52
2003|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.1|  0.4|18|78139655|52
2003|XI(b) Thyroid carcinomas|0-14|Incidence|  2.2|  1.8|  2.6|128|58432094|53
2003|XI(b) Thyroid carcinomas|0-19|Incidence|  6.1|  5.6|  6.7|479|78139655|53
2003|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|~|~|~|~|58432094|54
2003|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.5|  0.9|51|78139655|54
2003|XI(d) Malignant melanomas|0-14|Incidence|  2.0|  1.6|  2.4|118|58432094|55
2003|XI(d) Malignant melanomas|0-19|Incidence|  6.0|  5.5|  6.6|473|78139655|55
2003|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|58432094|56
2003|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|78139655|56
2003|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.8|  1.4|  2.1|104|58432094|57
2003|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.1|  3.7|  4.6|326|78139655|57
2003|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.7|  0.5|  0.9|39|58432094|58
2003|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.9|  0.7|  1.1|68|78139655|58
2003|XII(a) Other specified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|19|58432094|59
2003|XII(a) Other specified malignant tumors|0-19|Incidence|  0.5|  0.3|  0.6|36|78139655|59
2003|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|20|58432094|60
2003|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.4|  0.3|  0.6|32|78139655|60
2003|Not classified by ICCC|0-14|Incidence|  0.3|  0.2|  0.5|18|58432094|61
2003|Not classified by ICCC|0-19|Incidence|  0.3|  0.2|  0.5|27|78139655|61
2004|All ICCC Groups Combined |0-14|Incidence|152.7|149.5|155.8|9165|59652836|1
2004|All ICCC Groups Combined |0-19|Incidence|166.9|164.1|169.8|13421|79981151|1
2004|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 49.0| 47.3| 50.8|2936|59652836|2
2004|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 44.2| 42.7| 45.6|3540|79981151|2
2004|I(a) Lymphoid leukemias|0-14|Incidence| 37.3| 35.8| 38.9|2230|59652836|3
2004|I(a) Lymphoid leukemias|0-19|Incidence| 32.0| 30.7| 33.2|2557|79981151|3
2004|I(b) Acute myeloid leukemias|0-14|Incidence|  7.7|  7.0|  8.4|462|59652836|4
2004|I(b) Acute myeloid leukemias|0-19|Incidence|  8.0|  7.4|  8.7|646|79981151|4
2004|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.4|  1.1|  1.7|83|59652836|5
2004|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  1.8|  1.5|  2.1|141|79981151|5
2004|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|  1.4|  1.1|  1.7|83|59652836|6
2004|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|  1.2|  1.0|  1.5|100|79981151|6
2004|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.3|  1.0|  1.6|78|59652836|7
2004|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.2|  1.0|  1.5|96|79981151|7
2004|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 15.7| 14.7| 16.8|941|59652836|8
2004|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 23.5| 22.5| 24.6|1891|79981151|8
2004|II(a) Hodgkin lymphomas|0-14|Incidence|  5.2|  4.7|  5.8|313|59652836|9
2004|II(a) Hodgkin lymphomas|0-19|Incidence| 11.6| 10.9| 12.4|934|79981151|9
2004|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.7|  6.1|  7.4|403|59652836|10
2004|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.3|  7.7|  9.0|669|79981151|10
2004|II(c) Burkitt lymphoma|0-14|Incidence|  2.4|  2.0|  2.8|141|59652836|11
2004|II(c) Burkitt lymphoma|0-19|Incidence|  2.3|  2.0|  2.7|184|79981151|11
2004|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.1|  0.8|  1.4|66|59652836|12
2004|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.9|  0.7|  1.1|71|79981151|12
2004|II(e) Unspecified lymphomas|0-14|Incidence|  0.3|  0.2|  0.5|18|59652836|13
2004|II(e) Unspecified lymphomas|0-19|Incidence|  0.4|  0.3|  0.6|33|79981151|13
2004|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 32.0| 30.6| 33.5|1910|59652836|14
2004|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 29.6| 28.4| 30.8|2361|79981151|14
2004|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  2.9|  2.5|  3.4|176|59652836|15
2004|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.7|  2.3|  3.1|215|79981151|15
2004|III(b) Astrocytomas|0-14|Incidence| 15.1| 14.2| 16.2|902|59652836|16
2004|III(b) Astrocytomas|0-19|Incidence| 14.6| 13.7| 15.4|1163|79981151|16
2004|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.6|  6.9|  8.4|455|59652836|17
2004|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.5|  5.9|  7.0|516|79981151|17
2004|III(d) Other gliomas|0-14|Incidence|  5.0|  4.4|  5.6|295|59652836|18
2004|III(d) Other gliomas|0-19|Incidence|  4.6|  4.2|  5.1|369|79981151|18
2004|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.8|  0.6|  1.1|50|59652836|19
2004|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.7|  0.6|  1.0|60|79981151|19
2004|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.5|  0.4|  0.8|32|59652836|20
2004|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.5|  0.3|  0.7|38|79981151|20
2004|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.6|  9.8| 11.4|646|59652836|21
2004|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.1|  7.5|  8.8|663|79981151|21
2004|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.4|  9.6| 11.2|634|59652836|22
2004|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  7.9|  7.3|  8.5|642|79981151|22
2004|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|~|~|~|~|59652836|23
2004|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|  0.3|  0.2|  0.4|21|79981151|23
2004|V Retinoblastoma|0-14|Incidence|  4.1|  3.6|  4.6|249|59652836|24
2004|V Retinoblastoma|0-19|Incidence|  3.0|  2.7|  3.4|249|79981151|24
2004|VI Renal tumors|0-14|Incidence|  7.7|  7.0|  8.5|465|59652836|25
2004|VI Renal tumors|0-19|Incidence|  6.2|  5.6|  6.7|495|79981151|25
2004|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  7.4|  6.7|  8.1|444|59652836|26
2004|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  5.6|  5.1|  6.2|452|79981151|26
2004|VI(b) Renal carcinomas|0-14|Incidence|  0.3|  0.2|  0.5|20|59652836|27
2004|VI(b) Renal carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|42|79981151|27
2004|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|59652836|28
2004|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|79981151|28
2004|VII Hepatic tumors|0-14|Incidence|  2.7|  2.3|  3.1|163|59652836|29
2004|VII Hepatic tumors|0-19|Incidence|  2.4|  2.1|  2.8|195|79981151|29
2004|VII(a) Hepatoblastoma|0-14|Incidence|  2.4|  2.0|  2.8|144|59652836|30
2004|VII(a) Hepatoblastoma|0-19|Incidence|  1.8|  1.5|  2.1|144|79981151|30
2004|VII(b) Hepatic carcinomas|0-14|Incidence|~|~|~|~|59652836|31
2004|VII(b) Hepatic carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|44|79981151|31
2004|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|59652836|32
2004|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|79981151|32
2004|VIII Malignant bone tumors|0-14|Incidence|  6.8|  6.1|  7.5|407|59652836|33
2004|VIII Malignant bone tumors|0-19|Incidence|  8.7|  8.1|  9.4|699|79981151|33
2004|VIII(a) Osteosarcomas|0-14|Incidence|  4.0|  3.5|  4.6|242|59652836|34
2004|VIII(a) Osteosarcomas|0-19|Incidence|  5.0|  4.6|  5.6|405|79981151|34
2004|VIII(b) Chondrosarcomas|0-14|Incidence|~|~|~|~|59652836|35
2004|VIII(b) Chondrosarcomas|0-19|Incidence|  0.5|  0.3|  0.7|39|79981151|35
2004|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.2|  1.8|  2.6|130|59652836|36
2004|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  2.6|  2.2|  2.9|206|79981151|36
2004|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.3|  0.2|  0.5|17|59652836|37
2004|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.5|  0.3|  0.6|38|79981151|37
2004|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|~|~|~|~|59652836|38
2004|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|~|~|~|~|79981151|38
2004|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.2|  9.4| 11.1|615|59652836|39
2004|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.7| 10.9| 12.4|939|79981151|39
2004|IX(a) Rhabdomyosarcomas|0-14|Incidence|  4.5|  4.0|  5.1|271|59652836|40
2004|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.2|  3.8|  4.7|338|79981151|40
2004|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.2|  0.9|  1.5|73|59652836|41
2004|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.3|  1.0|  1.5|103|79981151|41
2004|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|59652836|42
2004|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|79981151|42
2004|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.5|  3.0|  4.0|209|59652836|43
2004|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.9|  4.5|  5.4|398|79981151|43
2004|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.8|  1.3|61|59652836|44
2004|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.2|  1.0|  1.5|96|79981151|44
2004|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.5|  5.0|  6.2|336|59652836|45
2004|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 11.0| 10.3| 11.7|889|79981151|45
2004|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.6|  1.3|  1.9|94|59652836|46
2004|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.8|  1.5|  2.1|142|79981151|46
2004|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.3|  1.0|  1.6|77|59652836|47
2004|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.2|  1.0|  1.5|102|79981151|47
2004|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.5|  2.1|  2.9|149|59652836|48
2004|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  7.3|  6.7|  7.9|592|79981151|48
2004|X(d) Gonadal carcinomas|0-14|Incidence|~|~|~|~|59652836|49
2004|X(d) Gonadal carcinomas|0-19|Incidence|  0.4|  0.3|  0.5|31|79981151|49
2004|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|~|~|~|~|59652836|50
2004|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.3|  0.2|  0.4|22|79981151|50
2004|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  7.3|  6.6|  8.0|438|59652836|51
2004|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 17.5| 16.6| 18.4|1412|79981151|51
2004|XI(a) Adrenocortical carcinomas|0-14|Incidence|~|~|~|~|59652836|52
2004|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.1|  0.3|17|79981151|52
2004|XI(b) Thyroid carcinomas|0-14|Incidence|  2.5|  2.1|  2.9|150|59652836|53
2004|XI(b) Thyroid carcinomas|0-19|Incidence|  6.5|  6.0|  7.1|528|79981151|53
2004|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.4|  0.2|  0.5|22|59652836|54
2004|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.5|  0.4|  0.7|44|79981151|54
2004|XI(d) Malignant melanomas|0-14|Incidence|  2.4|  2.1|  2.9|147|59652836|55
2004|XI(d) Malignant melanomas|0-19|Incidence|  6.3|  5.7|  6.8|506|79981151|55
2004|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|59652836|56
2004|XI(e) Skin carcinomas|0-19|Incidence|~|~|~|~|79981151|56
2004|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.6|  1.3|  2.0|97|59652836|57
2004|XI(f) Other and unspecified carcinomas|0-19|Incidence|  3.8|  3.4|  4.3|308|79981151|57
2004|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.6|  0.4|  0.8|37|59652836|58
2004|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.7|  0.5|  0.9|56|79981151|58
2004|XII(a) Other specified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|19|59652836|59
2004|XII(a) Other specified malignant tumors|0-19|Incidence|  0.4|  0.2|  0.5|29|79981151|59
2004|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.5|18|59652836|60
2004|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.3|  0.2|  0.5|27|79981151|60
2004|Not classified by ICCC|0-14|Incidence|  0.4|  0.2|  0.5|22|59652836|61
2004|Not classified by ICCC|0-19|Incidence|  0.4|  0.3|  0.6|32|79981151|61
2002-2004|All ICCC Groups Combined |0-14|Incidence|151.6|149.8|153.5|25700|168885230|1
2002-2004|All ICCC Groups Combined |0-19|Incidence|166.9|165.2|168.6|37808|225940535|1
2002-2004|I Leukemias, myeloproliferative & myelodysplastic diseases|0-14|Incidence| 48.2| 47.2| 49.3|8146|168885230|2
2002-2004|I Leukemias, myeloproliferative & myelodysplastic diseases|0-19|Incidence| 43.7| 42.9| 44.6|9878|225940535|2
2002-2004|I(a) Lymphoid leukemias|0-14|Incidence| 36.5| 35.6| 37.4|6150|168885230|3
2002-2004|I(a) Lymphoid leukemias|0-19|Incidence| 31.3| 30.6| 32.0|7059|225940535|3
2002-2004|I(b) Acute myeloid leukemias|0-14|Incidence|  7.7|  7.3|  8.1|1309|168885230|4
2002-2004|I(b) Acute myeloid leukemias|0-19|Incidence|  8.0|  7.6|  8.4|1819|225940535|4
2002-2004|I(c) Chronic myeloproliferative diseases|0-14|Incidence|  1.4|  1.2|  1.6|237|168885230|5
2002-2004|I(c) Chronic myeloproliferative diseases|0-19|Incidence|  1.9|  1.7|  2.1|437|225940535|5
2002-2004|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-14|Incidence|  1.5|  1.3|  1.7|250|168885230|6
2002-2004|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|0-19|Incidence|  1.4|  1.2|  1.5|310|225940535|6
2002-2004|I(e) Unspecified and other specified leukemias|0-14|Incidence|  1.2|  1.0|  1.4|200|168885230|7
2002-2004|I(e) Unspecified and other specified leukemias|0-19|Incidence|  1.1|  1.0|  1.3|253|225940535|7
2002-2004|II Lymphomas and reticuloendothelial neoplasms|0-14|Incidence| 15.7| 15.1| 16.3|2655|168885230|8
2002-2004|II Lymphomas and reticuloendothelial neoplasms|0-19|Incidence| 23.9| 23.3| 24.5|5418|225940535|8
2002-2004|II(a) Hodgkin lymphomas|0-14|Incidence|  5.4|  5.1|  5.8|923|168885230|9
2002-2004|II(a) Hodgkin lymphomas|0-19|Incidence| 12.0| 11.6| 12.5|2730|225940535|9
2002-2004|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-14|Incidence|  6.4|  6.0|  6.8|1079|168885230|10
2002-2004|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|0-19|Incidence|  8.2|  7.8|  8.6|1853|225940535|10
2002-2004|II(c) Burkitt lymphoma|0-14|Incidence|  2.6|  2.4|  2.8|435|168885230|11
2002-2004|II(c) Burkitt lymphoma|0-19|Incidence|  2.5|  2.3|  2.8|573|225940535|11
2002-2004|II(d) Miscellaneous lymphoreticular neoplasms|0-14|Incidence|  1.1|  0.9|  1.2|182|168885230|12
2002-2004|II(d) Miscellaneous lymphoreticular neoplasms|0-19|Incidence|  0.8|  0.7|  1.0|191|225940535|12
2002-2004|II(e) Unspecified lymphomas|0-14|Incidence|  0.2|  0.2|  0.3|36|168885230|13
2002-2004|II(e) Unspecified lymphomas|0-19|Incidence|  0.3|  0.2|  0.4|71|225940535|13
2002-2004|III CNS and misc intracranial and intraspinal neoplasms|0-14|Incidence| 32.4| 31.5| 33.3|5463|168885230|14
2002-2004|III CNS and misc intracranial and intraspinal neoplasms|0-19|Incidence| 29.6| 28.9| 30.4|6688|225940535|14
2002-2004|III(a) Ependymomas and choroid plexus tumor|0-14|Incidence|  3.0|  2.7|  3.3|508|168885230|15
2002-2004|III(a) Ependymomas and choroid plexus tumor|0-19|Incidence|  2.6|  2.4|  2.9|600|225940535|15
2002-2004|III(b) Astrocytomas|0-14|Incidence| 15.3| 14.8| 15.9|2587|168885230|16
2002-2004|III(b) Astrocytomas|0-19|Incidence| 14.5| 14.0| 15.0|3281|225940535|16
2002-2004|III(c) Intracranial and intraspinal embryonal tumors|0-14|Incidence|  7.5|  7.1|  7.9|1260|168885230|17
2002-2004|III(c) Intracranial and intraspinal embryonal tumors|0-19|Incidence|  6.4|  6.0|  6.7|1432|225940535|17
2002-2004|III(d) Other gliomas|0-14|Incidence|  5.4|  5.1|  5.8|909|168885230|18
2002-2004|III(d) Other gliomas|0-19|Incidence|  5.0|  4.7|  5.3|1123|225940535|18
2002-2004|III(e) Other specified intracranial & intraspinal neoplasms|0-14|Incidence|  0.8|  0.6|  0.9|131|168885230|19
2002-2004|III(e) Other specified intracranial & intraspinal neoplasms|0-19|Incidence|  0.7|  0.6|  0.8|163|225940535|19
2002-2004|III(f) Unspecified intracranial and intraspinal neoplasms|0-14|Incidence|  0.4|  0.3|  0.5|68|168885230|20
2002-2004|III(f) Unspecified intracranial and intraspinal neoplasms|0-19|Incidence|  0.4|  0.3|  0.5|89|225940535|20
2002-2004|IV Neuroblastoma and other peripheral nervous cell tumors|0-14|Incidence| 10.6| 10.1| 11.1|1804|168885230|21
2002-2004|IV Neuroblastoma and other peripheral nervous cell tumors|0-19|Incidence|  8.1|  7.7|  8.5|1847|225940535|21
2002-2004|IV(a) Neuroblastoma and ganglioneuroblastoma|0-14|Incidence| 10.4|  9.9| 10.9|1780|168885230|22
2002-2004|IV(a) Neuroblastoma and ganglioneuroblastoma|0-19|Incidence|  7.9|  7.5|  8.3|1801|225940535|22
2002-2004|IV(b) Other peripheral nervous cell tumors|0-14|Incidence|  0.1|  0.1|  0.2|24|168885230|23
2002-2004|IV(b) Other peripheral nervous cell tumors|0-19|Incidence|  0.2|  0.1|  0.3|46|225940535|23
2002-2004|V Retinoblastoma|0-14|Incidence|  3.9|  3.6|  4.2|669|168885230|24
2002-2004|V Retinoblastoma|0-19|Incidence|  2.9|  2.7|  3.2|671|225940535|24
2002-2004|VI Renal tumors|0-14|Incidence|  8.1|  7.7|  8.6|1377|168885230|25
2002-2004|VI Renal tumors|0-19|Incidence|  6.4|  6.1|  6.7|1447|225940535|25
2002-2004|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-14|Incidence|  7.8|  7.4|  8.3|1326|168885230|26
2002-2004|VI(a) Nephroblastoma and other nonepithelial renal tumors|0-19|Incidence|  5.9|  5.6|  6.2|1339|225940535|26
2002-2004|VI(b) Renal carcinomas|0-14|Incidence|  0.3|  0.2|  0.4|45|168885230|27
2002-2004|VI(b) Renal carcinomas|0-19|Incidence|  0.4|  0.4|  0.5|102|225940535|27
2002-2004|VI(c) Unspecified malignant renal tumors|0-14|Incidence|~|~|~|~|168885230|28
2002-2004|VI(c) Unspecified malignant renal tumors|0-19|Incidence|~|~|~|~|225940535|28
2002-2004|VII Hepatic tumors|0-14|Incidence|  2.4|  2.2|  2.6|408|168885230|29
2002-2004|VII Hepatic tumors|0-19|Incidence|  2.1|  1.9|  2.3|479|225940535|29
2002-2004|VII(a) Hepatoblastoma|0-14|Incidence|  2.0|  1.8|  2.2|341|168885230|30
2002-2004|VII(a) Hepatoblastoma|0-19|Incidence|  1.5|  1.3|  1.7|342|225940535|30
2002-2004|VII(b) Hepatic carcinomas|0-14|Incidence|  0.3|  0.3|  0.4|59|168885230|31
2002-2004|VII(b) Hepatic carcinomas|0-19|Incidence|  0.6|  0.5|  0.7|128|225940535|31
2002-2004|VII(c) Unspecified malignant hepatic tumors|0-14|Incidence|~|~|~|~|168885230|32
2002-2004|VII(c) Unspecified malignant hepatic tumors|0-19|Incidence|~|~|~|~|225940535|32
2002-2004|VIII Malignant bone tumors|0-14|Incidence|  6.8|  6.4|  7.2|1151|168885230|33
2002-2004|VIII Malignant bone tumors|0-19|Incidence|  8.8|  8.4|  9.2|1995|225940535|33
2002-2004|VIII(a) Osteosarcomas|0-14|Incidence|  3.8|  3.5|  4.1|652|168885230|34
2002-2004|VIII(a) Osteosarcomas|0-19|Incidence|  5.0|  4.8|  5.3|1146|225940535|34
2002-2004|VIII(b) Chondrosarcomas|0-14|Incidence|  0.2|  0.1|  0.3|33|168885230|35
2002-2004|VIII(b) Chondrosarcomas|0-19|Incidence|  0.4|  0.3|  0.5|94|225940535|35
2002-2004|VIII(c) Ewing tumor and related sarcomas of bone|0-14|Incidence|  2.3|  2.1|  2.6|395|168885230|36
2002-2004|VIII(c) Ewing tumor and related sarcomas of bone|0-19|Incidence|  2.7|  2.5|  3.0|622|225940535|36
2002-2004|VIII(d) Other specified malignant bone tumors|0-14|Incidence|  0.3|  0.2|  0.4|51|168885230|37
2002-2004|VIII(d) Other specified malignant bone tumors|0-19|Incidence|  0.4|  0.4|  0.5|99|225940535|37
2002-2004|VIII(e) Unspecified malignant bone tumors|0-14|Incidence|  0.1|  0.1|  0.2|20|168885230|38
2002-2004|VIII(e) Unspecified malignant bone tumors|0-19|Incidence|  0.1|  0.1|  0.2|34|225940535|38
2002-2004|IX Soft tissue and other extraosseous sarcomas|0-14|Incidence| 10.6| 10.1| 11.1|1791|168885230|39
2002-2004|IX Soft tissue and other extraosseous sarcomas|0-19|Incidence| 11.8| 11.4| 12.3|2684|225940535|39
2002-2004|IX(a) Rhabdomyosarcomas|0-14|Incidence|  5.0|  4.7|  5.4|851|168885230|40
2002-2004|IX(a) Rhabdomyosarcomas|0-19|Incidence|  4.7|  4.4|  5.0|1057|225940535|40
2002-2004|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-14|Incidence|  1.1|  1.0|  1.3|191|168885230|41
2002-2004|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|0-19|Incidence|  1.3|  1.1|  1.4|291|225940535|41
2002-2004|IX(c) Kaposi sarcoma|0-14|Incidence|~|~|~|~|168885230|42
2002-2004|IX(c) Kaposi sarcoma|0-19|Incidence|~|~|~|~|225940535|42
2002-2004|IX(d) Other specified soft tissue sarcomas|0-14|Incidence|  3.4|  3.1|  3.7|579|168885230|43
2002-2004|IX(d) Other specified soft tissue sarcomas|0-19|Incidence|  4.7|  4.4|  5.0|1074|225940535|43
2002-2004|IX(e) Unspecified soft tissue sarcomas|0-14|Incidence|  1.0|  0.8|  1.1|167|168885230|44
2002-2004|IX(e) Unspecified soft tissue sarcomas|0-19|Incidence|  1.1|  1.0|  1.3|255|225940535|44
2002-2004|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-14|Incidence|  5.4|  5.0|  5.7|919|168885230|45
2002-2004|X Germ cell, trophoblastic tumors & neoplasms of gonads|0-19|Incidence| 10.9| 10.5| 11.4|2489|225940535|45
2002-2004|X(a) Intracranial & intraspinal germ cell tumors|0-14|Incidence|  1.4|  1.2|  1.6|235|168885230|46
2002-2004|X(a) Intracranial & intraspinal germ cell tumors|0-19|Incidence|  1.6|  1.4|  1.8|365|225940535|46
2002-2004|X(b) Malignant extracranial & extragonadal germ cell tumors|0-14|Incidence|  1.4|  1.2|  1.6|243|168885230|47
2002-2004|X(b) Malignant extracranial & extragonadal germ cell tumors|0-19|Incidence|  1.4|  1.3|  1.6|331|225940535|47
2002-2004|X(c) Malignant gonadal germ cell tumors|0-14|Incidence|  2.4|  2.1|  2.6|404|168885230|48
2002-2004|X(c) Malignant gonadal germ cell tumors|0-19|Incidence|  7.2|  6.9|  7.6|1642|225940535|48
2002-2004|X(d) Gonadal carcinomas|0-14|Incidence|  0.1|  0.1|  0.2|17|168885230|49
2002-2004|X(d) Gonadal carcinomas|0-19|Incidence|  0.4|  0.3|  0.4|82|225940535|49
2002-2004|X(e) Other and unspecified malignant gonadal tumors|0-14|Incidence|  0.1|  0.1|  0.2|20|168885230|50
2002-2004|X(e) Other and unspecified malignant gonadal tumors|0-19|Incidence|  0.3|  0.2|  0.4|69|225940535|50
2002-2004|XI Other malignant epithelial neoplasms and malignant melanomas|0-14|Incidence|  6.8|  6.4|  7.2|1155|168885230|51
2002-2004|XI Other malignant epithelial neoplasms and malignant melanomas|0-19|Incidence| 17.4| 16.9| 18.0|3957|225940535|51
2002-2004|XI(a) Adrenocortical carcinomas|0-14|Incidence|  0.2|  0.2|  0.3|41|168885230|52
2002-2004|XI(a) Adrenocortical carcinomas|0-19|Incidence|  0.2|  0.2|  0.3|53|225940535|52
2002-2004|XI(b) Thyroid carcinomas|0-14|Incidence|  2.2|  2.0|  2.4|371|168885230|53
2002-2004|XI(b) Thyroid carcinomas|0-19|Incidence|  6.1|  5.8|  6.4|1390|225940535|53
2002-2004|XI(c) Nasopharyngeal carcinomas|0-14|Incidence|  0.3|  0.2|  0.4|47|168885230|54
2002-2004|XI(c) Nasopharyngeal carcinomas|0-19|Incidence|  0.6|  0.5|  0.7|141|225940535|54
2002-2004|XI(d) Malignant melanomas|0-14|Incidence|  2.3|  2.0|  2.5|385|168885230|55
2002-2004|XI(d) Malignant melanomas|0-19|Incidence|  6.3|  6.0|  6.6|1429|225940535|55
2002-2004|XI(e) Skin carcinomas|0-14|Incidence|~|~|~|~|168885230|56
2002-2004|XI(e) Skin carcinomas|0-19|Incidence|  0.1|  0.1|  0.2|25|225940535|56
2002-2004|XI(f) Other and unspecified carcinomas|0-14|Incidence|  1.7|  1.5|  1.9|296|168885230|57
2002-2004|XI(f) Other and unspecified carcinomas|0-19|Incidence|  4.0|  3.8|  4.3|919|225940535|57
2002-2004|XII Other and unspecified malignant neoplasms|0-14|Incidence|  0.6|  0.5|  0.7|102|168885230|58
2002-2004|XII Other and unspecified malignant neoplasms|0-19|Incidence|  0.8|  0.6|  0.9|172|225940535|58
2002-2004|XII(a) Other specified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.4|56|168885230|59
2002-2004|XII(a) Other specified malignant tumors|0-19|Incidence|  0.4|  0.3|  0.5|96|225940535|59
2002-2004|XII(b) Other unspecified malignant tumors|0-14|Incidence|  0.3|  0.2|  0.4|46|168885230|60
2002-2004|XII(b) Other unspecified malignant tumors|0-19|Incidence|  0.3|  0.3|  0.4|76|225940535|60
2002-2004|Not classified by ICCC|0-14|Incidence|  0.4|  0.3|  0.5|60|168885230|61
2002-2004|Not classified by ICCC|0-19|Incidence|  0.4|  0.3|  0.5|83|225940535|61
